VEGFA and prostate carcinoma: In terms of tumor angiogenesis, SFN has been reported to inhibit NF-κB-regulated VEGF expression in human prostate cancer cells29; and hypoxia-induced HIF-1α and VEGF expression in human colon cancer cells30.